ホーム>>Signaling Pathways>> MAPK Signaling>> ERK>>AX-15836

AX-15836

カタログ番号GC31667

AX-15836 は、8 nM の IC50 を持つ強力かつ選択的な ERK5 阻害剤です。

Products are for research use only. Not for human use. We do not sell to patients.

AX-15836 化学構造

Cas No.: 2035509-96-5

サイズ 価格 在庫数 個数
10mM (in 1mL DMSO)
$249.00
在庫あり
2mg
$101.00
在庫あり
5mg
$175.00
在庫あり
10mg
$258.00
在庫あり
25mg
$534.00
在庫あり
50mg
$901.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

AX-15836 is a potent and selective ERK5 inhibitor with an IC50 of 8 nM.

AX-15836 shows more than 1,000-fold selectivity for ERK5 over a panel of over 200 kinases. It also exhibits selectivity over BRD4 with a Kd of 3,600 nM. AX15836 shows similar intracellular potency (4-9 nM) across all cells tested, including peripheral blood mononuclear cells (PBMCs), endothelial cells, and oncogenic cell lines. AX15836 was completely ineffective (EC50>10 μM) to suppress inflammatory cytokine response, suggesting that it was the BRD inhibition component of the compounds that mediated cytokine reduction. In HUVEC and HeLa cell types, samples treated with AX15836 shows very few genes to be differentially expressed. AX15836 could clearly inhibit the EGF-stimulated, phosphorylated form of ERK5 in HeLa cells[1].

[1]. Lin EC, et al. ERK5 kinase activity is dispensable for cellular immune response and proliferation. Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):11865-11870.

レビュー

Review for AX-15836

Average Rating: 5 ★★★★★ (Based on Reviews and 20 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for AX-15836

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.